Exhaled Air Metabolome Analysis for Pulmonary Arterial Hypertension Fingerprints Identification—The Preliminary Study
Authors:
- Andrzej S. SwinarewAndrzej S. Swinarew
- Jadwiga GaborJGJadwiga Gabor
- Błażej KuszBKBłażej Kusz
- Szymon SkoczyńskiSSSzymon Skoczyński
- Paweł RaifPRPaweł Raif
- Ilona SkoczylasISIlona Skoczylas
- Kamil JonasKJKamil Jonas
- Marek GrabkaMGMarek Grabka
- Magdalena Mizia-SzubrytMMMagdalena Mizia-Szubryt
- Karolina BulaKBKarolina Bula
- Arkadiusz StanulaArkadiusz Stanula
- Barbara MikaBMBarbara Mika
Open Access
- 28 December 2022
- journal article
- research article
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 20 (1) , 503
Abstract
Pulmonary arterial hypertension (PAH) is a rare disease with a serious prognosis. The aim of this study was to identify biomarkers for PAH in the breath phase and to prepare an automatic classification method to determine the changing metabolome trends and molecular mapping. A group of 37 patients (F/M: 8/29 women, mean age 60.4 ± 10.9 years, BMI 27.6 ± 6.0 kg/m2) with diagnosed PAH were enrolled in the study. The breath phase of all the patients was collected on a highly porous septic material using a special patented holder PL230578, OHIM 002890789-0001. The collected air was then examined with gas chromatography coupled with mass spectrometry (GC/MS). The algorithms of Spectral Clustering, KMeans, DBSCAN, and hierarchical clustering methods were used to perform the cluster analysis. The identification of the changes in the ratio of the whole spectra of biomarkers allowed us to obtain a multidimensional pathway for PAH characteristics and showed the metabolome differences in the four subgroups divided by the cluster analysis. The use of GC/MS, supported with novel porous polymeric materials, for the breath phase analysis seems to be a useful tool in selecting bio-fingerprints in patients with PAH. The four metabolome classes which were obtained constitute novel data in the PAH population.Keywords
Funding Information
- institutional budget of the National Science Centre (UMO-2017/25/N/NZ5/02663, 2017/25/N/NZ5/02663)
This publication has 22 references indexed in Scilit:
- Pulmonary arterial hypertension associated with congenital heart disease: Recent advances and future directionsInternational Journal of Cardiology, 2014
- Taking your breath away: metabolomics breathes life in to personalized medicineTrends in Biotechnology, 2014
- The Emerging Role of Metabolomics in the Development of Biomarkers for Pulmonary Hypertension and other Cardiovascular Diseases (2013 Grover Conference Series)Pulmonary Circulation, 2014
- The Metabolic Basis of Pulmonary Arterial HypertensionCell Metabolism, 2014
- Metabolic dysfunction in pulmonary hypertension: the expanding relevance of the Warburg effectEuropean Journal of Clinical Investigation, 2013
- Metabolomic Profiling for the Identification of Novel Biomarkers and Mechanisms Related to Common Cardiovascular DiseasesCirculation, 2012
- Gene Expression Profiling in the Lungs of Patients With Pulmonary Hypertension Associated With Pulmonary FibrosisChest, 2012
- The great challenge for exhaled breath analysis: embracing complexity, delivering simplicityJournal of Breath Research, 2011
- Analysis of Volatile Organic Compounds in the Exhaled Breath for the Diagnosis of Lung CancerJournal of Thoracic Oncology, 2008
- Determination of ethane, pentane and isoprene in exhaled air – effects of breath‐holding, flow rate and purified airActa Physiologica, 2007